Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.
Formation Bio has raised $372.0M in total funding. The most recent round was Series D. The last funding was announced in June 2024.
Formation Bio's investors include Andreessen Horowitz, Sequoia Capital, Thrive Capital, SV Angel, Spark Capital.
Formation Bio is headquartered in New York, United States.
Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.
Formation Bio is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Formation Bio — Funding & Investors." VCBacked, June 26, 2024, https://www.vcbacked.co/company/formation-bio. Accessed October 29, 2026.
VCBacked. (2024). Formation Bio — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/formation-bio
{{cite web |title=Formation Bio — Funding & Investors |url=https://www.vcbacked.co/company/formation-bio |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated